Posts from statnews.com
Sort:
4
STAT+: Practice-changing results reported for Revolution Medicines pancreatic cancer drug

STAT+: Practice-changing results reported for Revolution Medicines pancreatic cancer drug

(statnews.com)
3
STAT+: Akeso and Summit’s ivonescimab extends survival in squamous cell lung cancer

STAT+: Akeso and Summit’s ivonescimab extends survival in squamous cell lung cancer

(statnews.com)
1
STAT+: BioNTech and Pfizer tout bispecifics data, and Pazdur sees silver lining at FDA

STAT+: BioNTech and Pfizer tout bispecifics data, and Pazdur sees silver lining at FDA

(statnews.com)
1
STAT+: Revolution Medicines starts shipping experimental pancreatic cancer drug

STAT+: Revolution Medicines starts shipping experimental pancreatic cancer drug

(statnews.com)
4
STAT+: China competition, ‘destruction’ at FDA give agency chance to restructure, Rick Pazdur says

STAT+: China competition, ‘destruction’ at FDA give agency chance to restructure, Rick Pazdur says

(statnews.com)
1
STAT+: At ASCO, positive data for Bristol in multiple myeloma and Pfizer in lung cancer

STAT+: At ASCO, positive data for Bristol in multiple myeloma and Pfizer in lung cancer

(statnews.com)
1
Opinion: I’m a weight-loss doctor. Here’s why I worry about GLP-1 ‘microdoses’

Opinion: I’m a weight-loss doctor. Here’s why I worry about GLP-1 ‘microdoses’

(statnews.com)
5
STAT+: Kailera’s own ‘triple-G’ drug also looks very powerful

STAT+: Kailera’s own ‘triple-G’ drug also looks very powerful

(statnews.com)
5
Opinion: Sen. Dick Durbin: Trump is letting Big Tobacco target children

Opinion: Sen. Dick Durbin: Trump is letting Big Tobacco target children

(statnews.com)
1
STAT+: How Kyle Diamantas defied expectations as he rose to lead the FDA

STAT+: How Kyle Diamantas defied expectations as he rose to lead the FDA

(statnews.com)
Click to load more
Create post Create new sub
Discover Communities
View all

No communities yet. Be the first to create one!